Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b
Comparative study published in Biochim Biophys Acta (1994)
Abstract
The genes for chymotrypsin inhibitors 1a and 1b (CI-1a and CI-1b) from barley have been expressed in E. coli, and the CI-1a and CI-1b proteins purified. These proteins, although highly homologous, differ in the active site region at P2, P1' and P3' (Schechter and Berger nomenclature), and so might be expected to have differing specificities. Despite this, analysis of the inhibition kinetics showed that each displayed very similar kinetic behaviour when tested against a range of proteinases. The specificity of the CI-1 proteins is different to that of the other main barley inhibitor, CI-2, and Ki values are found to follow the series subtilisin Carlsberg < neutrophil elastase approximately subtilisin BPN' << chymotrypsin. Only very weak inhibition is found of trypsin, and pancreatic elastase is not measurably inhibited. For the proteinases inhibited most strongly, characteristic slow-binding inhibition kinetics were observed, whereas classical inhibition applied to the weaker interactions. The results are consistent with the major determinant of specificity being the P1 residue of the inhibitor, which is the same in both CI-1a and CI-1b. Consistent with this, is the similar spectrum of specificity found for the homologous inhibitor eglin c from leech, which has the same P1 residue. Both the CI-1 proteins are found to be less stable than CI-2, with CI-1a being significantly less stable than CI-1b as measured by guanidinium hydrochloride unfolding experiments. Possible reasons for the reduced stability are discussed in view of the sequence differences between CI-1a, CI-1b and CI-2.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Comparison of barley chymotrypsin inhibitors with leech eglin c; eglin c shares similar P1 residue specificity for subtilisin and neutrophil elastase.
Warum dies für die Hirudotherapie relevant ist
This comparative study expressed and purified barley chymotrypsin inhibitors CI-1a and CI-1b in E. coli and characterized their inhibition kinetics against a range of proteinases, finding similar behavior between the two despite active-site sequence differences, with specificity driven primarily by the shared P1 residue. The study is only tangentially relevant to ASH's domain: it briefly notes that the homologous inhibitor eglin c from leech shares the same P1 residue and a similar specificity spectrum, but the work itself concerns plant protease inhibitors, not leeches or hirudotherapy. The abstract makes no therapeutic claims and provides no leech-derived data. The honest caveat is that this article involves no leech experiments, no leech secretome analysis, and no hirudotherapy relevance beyond a passing structural comparison; its inclusion in an ASH library would be limited to indirect contextual value regarding inhibitor structure-activity relationships.
Zitation
Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.
Greagg MA et al. · Biochim Biophys Acta, 1994
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026